Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis? (2019)
- Authors:
- Autor USP: ABDALA, EDSON - FM
- Unidade: FM
- DOI: 10.1111/myc.12901
- Subjects: FÁRMACOS IMUNOSSUPRESSORES; FUSARIUM; PREVENÇÃO DE DOENÇAS
- Language: Inglês
- Imprenta:
- Source:
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
NUCCI, Marcio et al. Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis?. Mycoses, v. 62, n. 5, p. 413-417, 2019Tradução . . Disponível em: https://doi.org/10.1111/myc.12901. Acesso em: 11 mar. 2026. -
APA
Nucci, M., Shoham, S., Abdala, E., Hamerschlak, N., Rico, J. C., Forghieri, F., et al. (2019). Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis? Mycoses, 62( 5), 413-417. doi:10.1111/myc.12901 -
NLM
Nucci M, Shoham S, Abdala E, Hamerschlak N, Rico JC, Forghieri F, Nouer SA, Cappellano P, Solza C, Gonzaga Y. Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis? [Internet]. Mycoses. 2019 ; 62( 5): 413-417.[citado 2026 mar. 11 ] Available from: https://doi.org/10.1111/myc.12901 -
Vancouver
Nucci M, Shoham S, Abdala E, Hamerschlak N, Rico JC, Forghieri F, Nouer SA, Cappellano P, Solza C, Gonzaga Y. Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis? [Internet]. Mycoses. 2019 ; 62( 5): 413-417.[citado 2026 mar. 11 ] Available from: https://doi.org/10.1111/myc.12901 - Management of hepatocellular carcinoma during the COVID-19 pandemic - Sao Paulo clinicas liver cancer group multidisciplinary consensus statement
- Analysis of spontaneous resolution of cytomegalovirus replication after transplantation in CMV-seropositive patients with pretransplant CD8+IFNG + response
- Thermal and chronological stability of monocyte distribution width (MDW), the new biomarker for sepsis. [Carta]
- Clinical profile and mortality predictors for tuberculosis disease among patients with solid tumours
- Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study
- Role of lock therapy for long-term catheter-related infections by multidrug-resistant bacteria
- Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America
- Antifungal and Antibacterial Activity of Terpenes for Improvement of Indoor Air Quality
- Contribuição científica para o manejo das infecções em transplantes de órgãos sólidos
- Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
